Software Healthcare Sector

Freenome

Market Cap: US$1.3b

Operates as a biotechnology company focused on developing blood-based tests for early cancer detection using artificial intelligence and multiomics technology.

MeiraGTx Holdings

Market Cap: US$1.3b

A clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.

Seaport Therapeutics

Market Cap: US$1.3b

A clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders.

Nutex Health

Market Cap: US$1.3b

Operates as a healthcare services and operations company in the United States.

Corvus Pharmaceuticals

Market Cap: US$1.3b

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

STAAR Surgical

Market Cap: US$1.3b

Designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

GoodRx Holdings

Market Cap: US$1.3b

Offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

Spire Healthcare Group

Market Cap: UK£937.4m

Owns and operates private hospitals and clinics in the United Kingdom.

Teladoc Health

Market Cap: US$1.3b

Provides virtual healthcare services worldwide.

Cullinan Therapeutics

Market Cap: US$1.3b

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Alto Neuroscience

Market Cap: US$1.3b

Operates as a clinical-stage biopharmaceutical company in the United States.

PROCEPT BioRobotics

Market Cap: US$1.3b

A surgical robotics company, develops transformative solutions in urology in the United States and internationally.

Omeros

Market Cap: US$1.3b

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Certara

Market Cap: US$1.2b

Provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific.

Ryman Healthcare

Market Cap: NZ$2.1b

Develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia.

U.S. Physical Therapy

Market Cap: US$1.2b

Operates and manages outpatient physical therapy clinics.

Latigo Biotherapeutics

Market Cap: US$1.2b

Develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction.

CVS Group

Market Cap: UK£894.5m

Engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia.

MannKind

Market Cap: US$1.2b

A biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.

Cronos Group

Market Cap: CA$1.6b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Bioventus

Market Cap: US$1.2b

A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.

EyePoint

Market Cap: US$1.2b

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

Lumexa Imaging Holdings

Market Cap: US$1.2b

Owns and operates diagnostic imaging centres in the United States.

Apnimed

Market Cap: US$1.1b

Operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets.

Summerset Group Holdings

Market Cap: NZ$1.9b

Develops, owns, and operates integrated retirement villages in New Zealand and Australia.

IRADIMED

Market Cap: US$1.1b

Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories.

Akso Health Group

Market Cap: US$1.1b

Operates a social e-commerce mobile platform in the People’s Republic of China.

Sana Biotechnology

Market Cap: US$1.1b

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Strive

Market Cap: US$1.1b

A privately owned investment manager.

OPKO Health

Market Cap: US$1.0b

Operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

Avalo Therapeutics

Market Cap: US$1.0b

A clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States.

Lexicon Pharmaceuticals

Market Cap: US$1.0b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.

QuidelOrtho

Market Cap: US$1.0b

Provides diagnostic testing solutions.

GMR Solutions

Market Cap: US$1.0b

Operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States.

Wave Life Sciences

Market Cap: US$1.0b

A clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health.

Ardelyx

Market Cap: US$1.0b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.